tranexamic acid in sodium chloride
Generic: tranexamic acid
Labeler: exela pharma sciences, llcDrug Facts
Product Profile
Brand Name
tranexamic acid in sodium chloride
Generic Name
tranexamic acid
Labeler
exela pharma sciences, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
tranexamic acid 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51754-0108
Product ID
51754-0108_0ae0a575-08e1-43a3-9b6c-8c5f165db35f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA212020
Listing Expiration
2026-12-31
Marketing Start
2019-06-01
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
517540108
Hyphenated Format
51754-0108
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tranexamic acid in sodium chloride (source: ndc)
Generic Name
tranexamic acid (source: ndc)
Application Number
NDA212020 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 100 mL in 1 BAG (51754-0108-1)
- 1000 mL in 1 CASE (51754-0108-3)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "0ae0a575-08e1-43a3-9b6c-8c5f165db35f", "openfda": {"nui": ["N0000175634", "N0000175632"], "unii": ["6T84R30KC1"], "rxcui": ["2170286"], "spl_set_id": ["db36ddf2-4ac5-47ac-bdce-e3fa6983073e"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "manufacturer_name": ["Exela Pharma Sciences, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mL in 1 BAG (51754-0108-1)", "package_ndc": "51754-0108-1", "marketing_start_date": "20190601"}, {"sample": false, "description": "1000 mL in 1 CASE (51754-0108-3)", "package_ndc": "51754-0108-3", "marketing_start_date": "20190601"}], "brand_name": "TRANEXAMIC ACID IN SODIUM CHLORIDE", "product_id": "51754-0108_0ae0a575-08e1-43a3-9b6c-8c5f165db35f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antifibrinolytic Agent [EPC]", "Decreased Fibrinolysis [PE]"], "product_ndc": "51754-0108", "generic_name": "tranexamic acid", "labeler_name": "Exela Pharma Sciences, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TRANEXAMIC ACID IN SODIUM CHLORIDE", "active_ingredients": [{"name": "TRANEXAMIC ACID", "strength": "10 mg/mL"}], "application_number": "NDA212020", "marketing_category": "NDA", "marketing_start_date": "20190601", "listing_expiration_date": "20261231"}